Shilpa Medicare
Shilpa Medicare announced the appointment of Dr. Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals, a wholly owned subsidiary of Shilpa Medicare. The appointment is effective 19 September 2024
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.